Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Metformin for Operable Breast Cancer Patients
NCT00909506Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Jun 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in breast cancer, sponsored by Seoul National University Hospital. Started Jun 2009; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00909506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00909506.